Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement
Clinical trial NCT07104604 · RECRUITING
Trial details
- NCT number
- NCT07104604
- Sponsor
- Affiliated Cancer Hospital of Shantou University Medical College
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-20
- Primary completion
- 2027-03-31
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.